Johnson & Johnson agrees to pay $230 million to settle opioid case in New York
On the eve of a widely anticipated trial, Johnson & Johnson (JNJ) has agreed to pay $230 million to the state of New York to settle a lawsuit alleging that the company helped fuel the devastating opioid crisis.
The deal comes as negotiations intensify with the health care giant and three of the nation’s largest pharmaceutical wholesalers to complete a sweeping $26 billion settlement of thousands of other lawsuits. The settlement includes an additional $33 million in attorney fees and costs, as well as a commitment from J&J to halt opioid sales, a step the company said it has already taken (you can read the settlement here).
